Form 4: Soleno Therapeutics Officer Sells Shares to Cover Tax Obligations

Patricia C. Hirano, a Senior Vice President at Soleno Therapeutics, sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On August 5th and 6th, 2024, Patricia C. Hirano, a Senior Vice President at Soleno Therapeutics, sold shares of the company's common stock.
• The sales were executed in multiple transactions at varying prices.
• The sales were conducted to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• Hirano sold a total of 2,834 shares on August 5th at a weighted average price of $45.4767.
• An additional 2,198 shares were sold on August 5th at a weighted average price of $46.1439.
• On August 6th, Hirano sold 587 shares at a weighted average price of $43.6397.
• Another 1,983 shares were sold on August 6th at a weighted average price of $45.2471.
• Finally, 3,407 shares were sold on August 6th at a weighted average price of $45.89.
• Following these transactions, Hirano directly owns 122,745 shares of Soleno Therapeutics common stock, some of which are RSUs.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales to cover tax obligations, a routine event.

Industry Context

Insider sales are a common occurrence, especially when related to covering tax obligations from vesting equity. It's important to consider the overall context of insider transactions, including the frequency, size, and reasons behind them, to assess their potential impact on investor sentiment.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares sold.

Key Dates